# Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP)

> **NCT03499483** · PHASE4 · COMPLETED · sponsor: **Fenway Community Health** · enrollment: 52 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** bictegravir

## Key facts

- **NCT ID:** NCT03499483
- **Lead sponsor:** Fenway Community Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-24
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-03-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499483, "Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03499483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*